Glucotrack, Inc. financial data

Symbol
GCTK on Nasdaq
Location
301 Rt 17 North, Suite 800, Rutherford, NJ
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 238 % +33.6%
Debt-to-equity -1.02K % -766%
Return On Equity 3.72K %
Return On Assets -403 % -23.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 899K shares -83.6%
Common Stock, Shares, Outstanding 899K shares -83.6%
Entity Public Float 8.6M USD +60.4%
Common Stock, Value, Issued 1K USD -80%
Weighted Average Number of Shares Outstanding, Basic 495K shares
Weighted Average Number of Shares Outstanding, Diluted 495K shares -89.2%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 8.78M USD -4.24%
Selling and Marketing Expense 128K USD +82.9%
General and Administrative Expense 6.08M USD +132%
Operating Income (Loss) -15.4M USD -27.4%
Net Income (Loss) Attributable to Parent -26.8M USD -122%
Earnings Per Share, Basic -894 USD/shares
Earnings Per Share, Diluted -894 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 9.56M USD +5909%
Other Assets, Current 522K USD +84.5%
Assets, Current 10.1M USD +2180%
Property, Plant and Equipment, Net 87K USD +1.16%
Operating Lease, Right-of-Use Asset 46K USD -35.2%
Assets 10.2M USD +1579%
Accounts Payable, Current 2.64M USD -3.36%
Liabilities, Current 3.09M USD -15.7%
Operating Lease, Liability, Noncurrent 19K USD -58.7%
Other Liabilities, Noncurrent 203K USD +3.57%
Liabilities 3.33M USD -14.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax 41K USD +86.4%
Retained Earnings (Accumulated Deficit) -144M USD -22.8%
Stockholders' Equity Attributable to Parent 6.88M USD
Liabilities and Equity 10.2M USD +1579%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.94M USD +0.1%
Net Cash Provided by (Used in) Financing Activities 6.4M USD
Net Cash Provided by (Used in) Investing Activities -9K USD +84.7%
Common Stock, Shares Authorized 250M shares +150%
Common Stock, Shares, Issued 899K shares -83.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3.48M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 5.63M USD +25%
Interest Paid, Excluding Capitalized Interest, Operating Activities 4K USD -85.7%
Deferred Tax Assets, Gross 20.5M USD +52%
Operating Lease, Liability 59K USD
Depreciation 4K USD -55.6%
Payments to Acquire Property, Plant, and Equipment 9K USD -84.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -26.7M USD -121%
Lessee, Operating Lease, Liability, to be Paid 65K USD
Operating Lease, Liability, Current 27K USD +8%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 6K USD
Deferred Tax Assets, Operating Loss Carryforwards 17M USD +37.3%
Operating Lease, Payments 3K USD
Additional Paid in Capital 855K USD
Depreciation, Depletion and Amortization 4K USD 0%
Interest Expense 5K USD